With all of the predictions about what milestone accomplishment will propel the inflection point, I actually think the inflection will happen on seemingly no news. The people looking closely at these trials are looking at small keys to the puzzle to solidify the true potential. Any BP watching this will likely be under some NDA and see the data in real time, even data that is not pr worthy. It might be a lunch conversation with a doctor of a trial patient, it might be an interesting piece of data that confirms a theory developed from past data, etc.. one thing for sure, what ever drives this could be any day for any reason. There are too many significant achievements that we predicted would be game changers that did very little at the time. Small events could be building the real significant change and it might be for some development that is quite small on its own.

Let’s remember, cytodyn owns the patents for ccr5 inhibitors in fighting cancer, data from marovac could drive inflection.